magrolimab,azacitidine
gilead sciences
['azacitidine,(-oral azaci),(-azacitidine oral)', 'magrolimab']
this afternoon at #asco22, dr. david sallman shares findings from a phase 1b study evaluating the use of magrolimab in combination with azacitidine for higher-risk myelodysplastic syndromes. view abstract: 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.